Aviv Pharma Inc. — Form D

Aviv Pharma Inc. of RENO, NV, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-28. The offering totals $4.0M, of which $2.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2023-12-28
• Form: D
• Accession: 0002005438-23-000001
• Industry: Pharmaceuticals
• Exemptions: 06c
• Total offering: $4.0M
• Amount sold: $2.3M
• Remaining: $1.7M
• Minimum investment: $25K
• Investors: 12
• Date of first sale: 2023-12-15
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-501052

Issuer

• Name: Aviv Pharma Inc.
• CIK: 0002005438
• Entity type: Corporation
• Jurisdiction: NEVADA
• Incorporated: 2022
• Address: 401 RYLAND STREET, RENO, NV, 89502
• Phone: 9179130408

Officers, directors & promoters (7)

More

• CIK 2005438 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search